Scientists have devised a technique that enables medication to reach affected organs directly, completely bypassing the liver.
Many treatments, from pain relievers to medications for chronic conditions, share a common side effect: Prolonged exposure can damage the liver.
Groundbreaking research by Tel Aviv University scientists may pave the way for liver-friendly medications. They have discovered a method to transport lipid nanoparticles encapsulating messenger RNA directly to the intestines, bypassing the liver.
Led by post-doctoral fellow Dr. Riccardo Rampado and Vice President for R&D Prof. Dan Peer—a pioneer in mRNA therapeutics and director of the Laboratory of Precision Nano-Medicine at the Shmunis School of Biomedical and Cancer Research—the revolutionary study was featured on the cover of the prestigious journal Advanced Science.
